Since the pioneer work of Duran-Reynals in 1928 (Duran-Reynals, 1942 , there has been a considerable investigation of spreading factors (Haas, 1946; Meyer, 1947) and their antagonists (Mayer and Kull, 1947; Wattenberg and Glick, 1949; Jones, 1950) , concerning especially the mucolytic polysaccharide " hyaluronidase" (Hobby and others, 1941) . Guerra (1946a, b) determined resistance to hyaluronidase by calculating the area of spread of intradermal weals of hyaluronidase dye combinations. Guerra and Robles Gil (1946) claimed that active and healed rheumatic fever patients have abnormal and rapid spreading reactions to testicular hyaluronidase. They suggested, therefore, that in rheumatic fever the mesenchymal tissues are especially involved, and that the rapid spread of inflammatory agents is evidence of removal of a protective ground-substance barrier. They also reported that therapeutic doses of salicylates inhibited these enzymatic spreading reactions and they concluded that the salutary effect of salicylates is mediated by this inhibition.
Although Dorfman and others (1947) corroborated the inhibitory effects of salicylates on hyaluronidase by animal experiments in vitro and in vivo, the in vitro inactivation of the hyaluronidase did not occur unless the concentrations of salicylates were greater than the usual therapeutic level and within the range in which salicylates denature biologically active proteins. Harris and Friedman (1949) , using haemoglobin as an indicator, were unable to demonstrate an increased susceptibility to streptococcus hyaluronidase in the tissues of rheumatic subjects. Ragan (1948) , using similar techniques, was also unable to confirm Guerra's results.
Recent interest in the relationship of the hyaluronic acid-hyaluronidase system to rheumatic fever has been stimulated by four observations (Waksman, 1949) :
(1) hyaluronic acid is an importapt constituent of connective tissue, the site of the rheumatic process;
(2) haemolytic streptococci produce hyaluronic acid and hyaluronidase; (3) hyaluronidase allegedly causes in the skin of patients with rheumatic fever spreading reactions which are inhibited by salicylates; (4) hyaluronic acid increases the sedimentation rate in vivo (in the rat) and in vitro, while hyaluronidase decreases the sedimentation rate in vitro even in the blood of rheumatic fever patients.
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Since the completion of our work, Shuman (1950) has studied the problem of inhibition of hyaluronidase, using fluorescein as an indicator dye, and has reported normal spreading reactions in eight untreated acute rheumatic fever subjects, in two patients with disseminated lupus erythematosus, and in four patients with rheumatic conditions other than rheumatic fever. He showed that in patients treated with salicylates, hyaluronidase was inhibited and the disappearance of the dye delayed. He also reported that intravenous heparin appeared to inhibit the action of hyaluronidase and that anti-histaminic drugs had no effect.
Our purposes in this study were:
(1) to determine whether subjects with acute rheumatic fever or other febrile conditions have an altered resistance to the spread of hyaluronidase as compared to normal subjects, (2) to observe the effects of salicylates on the spread of hyaluronidase weals in patients with acute rheumatic fever and in normal subjects. Methods One ml. of a solution of a 1 per cent. Evans blue (T1824) in saline was added to 150 turbidity reducing units of hyaluronidase.* Intradermal weals were made in the volar surface of the right forearm by injecting exactly 0L 1 ml. of the hyaluronidase/Evans blue solution, using tuberculin syringes, the plungers and tips of which were treated with bisilicon petcock grease to prevent leakage and facilitate the injection of accurate amounts.
A 4-in. 27-gauge intradermal needle was used. As controls, weals were produced on the corresponding' site of the left forearm, using 0-1 ml. of the 1 per cent. sterile Evans blue solution in saline. Since it was found that the maximum spread took place after 24 hrs, all measurements were made at this time interval. The area of spread was calculated as suggested by Harris and Friedman (1949) . The longest axis of the spread area and its perpendicular were measured at the end of 24 hrs. Since the area of an ellipse is computed by the formula:
Area= 4 (where D is the long axis, and d the perpendicular), the hyaluronidase area can be obtained by multiplying the product of the two axes by 0-785 mm. The area of spread is the hyaluronidase area minus the control area in square millimetres.
To control the joint pain in the rheumatic subjects prior to administration of salicylates, codeine was necessary on occasion. The level of salicylates in the blood was determined during the 24-hr period of spread (Brodie and others, 1944) .
Material
The patients for this investigation, selected from the Children's Hospital and the adult wards of the Cook County Hospital, were Negro and white, and ranged from 5 to 43 years of age.
Group I: Sixteen subjects in various stages of acute rheumatic fever and its chronic sequelae. No salicylates or anti-rheumatic drugs were administered before or during the course of the test (Table J) .
Group I1: Eight subjects with acute rheumatic fever. The skin tests were performed before and repeated during the administration of salicylates. The level of blood salicylate was determined within the 24-hr test period (Brodie and others, 1944) . Only typical cases oPrheumatic fever were selected. Borderline cases lacking the usual criteria were rejected from the study (Table II) .
Group IIl: 28 adult patients with a wide variety of conditions, including cases of ANNALS OF THE RHEUMATIC DISEASES acute rheumatoid arthritis, acute gastro-enteritis, pneumonia, active pulmonary tuberculosis, acute pelvic inflammatory disease, acute upper respiratory tract infections, and several of the collagen diseases. None of the patients in this group received salicylates before or during the test (Table III) .
Group IV: Fourteen normal young adult males. The test was carried out before and repeated during the administration of therapeutic doses of salicylates. Salicylate blood levels were also obtained during the test period. To establish maximum concentration of salicylates in the tissues, the drug was given for 48 hrs before the test period as well as during the period of reaction (Table IV) (1950) , in that we were unable to discern in rheumatic fever subjects any unusual to 53 4 sq. mm., 16 being the arithmetical average for fourteen normal subjects. With such a wide span of values in the normal group, the discernment of statistically significant areas of spread in pathological conditions is obviously inconclusive. In general, spreading reactions in the acute rheumatic fever group were not significantly different from those in the normal group. The controlled administration of therapeutic doses of salicylates to eight subjects with acute rheumatic fever (Group II) reduced the area of spread significantly in six cases, whereas in two cases the area of spread was slightly larger during salicylate administration. Spreading reactions in subjects with inflammatory conditions and collagen diseases (Group III)* were also within the normal range. This is especially noteworthy in the several patients with collagen diseases.
* Case 14 (Group IlI), with active hyperthyroidism, had an excessively large area of spread which may be attributed to the increased vascularity of the tissues rather than decreased resistance to hyaluronidase. In ten of the fourteen normal controls (Group IV), administration of salicylates significantly reduced the area of the spreading reaction. In four of this group, the area of spread after the administration of salicylates was the same or even larger, 424 indicating that there is a considerable variation in anti-hyaluronidase factors in normal individuals. Assay of anti-hyaluronidase factors (Haas, 1946; Harris and others, 1950; Thompson and Moses, 1949) would have been highly valuable but was not obtainable in this project.
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Comment
The only explanation we have to offer for the discrepancy between Guerra's results and our own is that he may have been dealing with an impure enzyme
